{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:06:29Z","timestamp":1753891589690,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019033","name":"Key Research and Development Program of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Neonatal diabetes mellitus (NDM) is a rare type of monogenic diabetes. At present, most published studies have focused on the types of gene mutations associated with NDM and the therapeutic effect of sulfonylureas (SUs) on the disease; few studies on NDM-associated intracranial hemorrhage (ICH) exist. In addition, p.V59M mutations generally lead to intermediate DEND (iDEND: intermediate developmental delay and neonatal diabetes) syndrome without epilepsy. Here, we present a case of a 1-month-old male infant who was diagnosed with NDM caused by a <jats:italic>KCNJ11<\/jats:italic> missense mutation (p.V59M), presenting with cerebral injury. In the early stage of the disease, continuous insulin dose adjustment did not achieve an ideal level of blood glucose. Although blood glucose was subsequently controlled by oral SUs, which were administered after the genetic test result, the patient still displayed epilepsy and developmental delay. In this case report, we present our experience in the treatment of the infant, switching from insulin to oral SUs and we thought that SUs have limited effects on improving the prognosis of neurodevelopmental disturbances in NDM with foci of encephalomalacia. In addition, there may be a relationship between <jats:italic>KCNJ11<\/jats:italic> missense mutations and cerebral injury, and further research must be carried out to confirm these points.<\/jats:p>","DOI":"10.3389\/fneur.2023.1072078","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T05:36:42Z","timestamp":1677821802000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: Neonatal diabetes mellitus caused by KCNJ11 mutation presenting with intracranial hemorrhage"],"prefix":"10.3389","volume":"14","author":[{"given":"Bo","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"108274","DOI":"10.18632\/oncotarget.22548","article-title":"Sulfonylurea for the treatment of neonatal diabetes owing to KATP-channel mutations: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget."},{"key":"B2","doi-asserted-by":"publisher","first-page":"540718","DOI":"10.3389\/fped.2020.540718","article-title":"Neonatal Diabetes Mellitus","volume":"8","author":"Beltrand","year":"2020","journal-title":"Front Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1515\/jpem-2016-0261","article-title":"Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus","volume":"30","author":"Kylat","year":"2017","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1007\/s00125-015-3593-9","article-title":"Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes","volume":"58","author":"Thurber","year":"2015","journal-title":"Diabetologia."},{"key":"B5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/pedi.12428","article-title":"ADHD, learning difficulties and sleep disturbances associated with KCNJ11-related neonatal diabetes","volume":"18","author":"Landmeier","year":"2017","journal-title":"Pediatr Diabetes."},{"key":"B6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Hattersley: Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1753-0407.13114","article-title":"Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature","volume":"13","author":"He","year":"2021","journal-title":"Diabetes J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)60098-8","article-title":"The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study","volume":"386","author":"De Franco","year":"2015","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.2337\/dc17-1145","article-title":"Diabetes presentation in infancy: high risk of diabetic ketoacidosis","volume":"40","author":"Letourneau","year":"2017","journal-title":"Diabetes Care."},{"key":"B10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.beem.2018.06.008","article-title":"Genetic causes and treatment of neonatal diabetes and early childhood diabetes","volume":"32","author":"Barbetti","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3969\/j.issn.1673-5293.2016.01.035","article-title":"Xinshener tangniaobing bingfa lunei chuxue yili baogao ji wenxianfuxi","volume":"27","author":"Yu","year":"2016","journal-title":"Chinese J Woman Child Health Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"F77","DOI":"10.1136\/fn.81.1.F77b","article-title":"Neonatal diabetes and severe intracerebral hemorrhage","volume":"81","author":"Manzar","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/pedi.12701","article-title":"ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state","volume":"19","author":"Wolfsdorf","year":"2018","journal-title":"Pediatr. Diabetes."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","article-title":"Activating mutations in Kir6","volume":"54","author":"Hattersley","year":"2005","journal-title":"Diabetes."},{"key":"B15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1464-5491.2007.02373.x","article-title":"Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation","volume":"25","author":"Slingerland","year":"2008","journal-title":"Diabet Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/pedi.12560","article-title":"Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: experience from China","volume":"19","author":"Li","year":"2018","journal-title":"Pediatr. Diabetes."},{"key":"B17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2337\/dc19-1013","article-title":"Intellectual disability in KATP channel neonatal diabetes","volume":"43","author":"Svalastoga","year":"2020","journal-title":"Diabetes Care."},{"key":"B18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S2213-8587(13)70059-7","article-title":"Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]","volume":"1","author":"Busiah","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.2337\/dc15-0837","article-title":"Sulfonylurea therapy benefits neurological and psychomotor functions in patients with neonatal diabetes owing to potassium channel mutations","volume":"38","author":"Beltrand","year":"2015","journal-title":"Diabetes Care."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.2337\/diabetes.53.10.2719","article-title":"Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients","volume":"53","author":"Vaxillaire","year":"2004","journal-title":"Diabetes."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3346\/jkms.2017.32.6.1042","article-title":"DEND syndrome with heterozygous KCNJ11 mutation successfully treated with sulfonylurea","volume":"32","author":"Cho","year":"2017","journal-title":"J. Korean Med. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/micc.12053","article-title":"Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction","volume":"20","author":"Close","year":"2013","journal-title":"Microcirculation."},{"key":"B23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2174\/1570159X14666160225155151","article-title":"Optic nerve and cerebral edema in the course of diabetic ketoacidosis","volume":"14","author":"Szmygel","year":"2016","journal-title":"Curr Neuropharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/pedi.13152","article-title":"Brain injury in children with diabetic ketoacidosis: review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema","volume":"22","author":"Azova","year":"2021","journal-title":"Pediatr. Diabetes."},{"key":"B25","doi-asserted-by":"publisher","first-page":"219706","DOI":"10.4061\/2011\/219706","article-title":"Diabetic ketoacidosis-associated stroke in children and youth","volume":"2011","author":"Foster","year":"2011","journal-title":"Stroke Res Treat."},{"key":"B26","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1399-5448.2009.00511.x","article-title":"Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved?","volume":"10","author":"Glaser","year":"2009","journal-title":"Pediatr Diabetes."},{"key":"B27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bbr.2016.10.047","article-title":"Diabetes mitigates the recovery following intracranial hemorrhage in rats","volume":"320","author":"Fan","year":"2017","journal-title":"Behav Brain Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"21590","DOI":"10.1038\/s41598-021-00939-7","article-title":"Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes","volume":"11","author":"Dalgin","year":"2021","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2337\/dc18-1060","article-title":"Cognitive, neurological, and behavioral features in adults With KCNJ11 neonatal diabetes","volume":"42","author":"Bowman","year":"2019","journal-title":"Diabetes Care."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.neuroscience.2006.10.043","article-title":"Kir6.2-containing ATP-sensitive potassium channels protect cortical neurons from ischemic\/anoxic injury in vitro and in vivo","volume":"144","author":"Sun","year":"2007","journal-title":"Neuroscience."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e13454","DOI":"10.1111\/eci.13454","article-title":"The role of potassium in atherosclerosis","volume":"51","author":"Sahranavard","year":"2021","journal-title":"Eur J Clin Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/brain\/124.9.1683","article-title":"Presurgical evaluation of epilepsy","volume":"124","author":"Rosenow","year":"2001","journal-title":"Brain."},{"key":"B33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1586\/14737175.2015.1025382","article-title":"Non-invasive EEG evaluation in epilepsy diagnosis","volume":"15","author":"Rosenow","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1523\/JNEUROSCI.3182-06.2007","article-title":"Recurrent circuits in layer II of medial entorhinal cortex in a model of temporal lobe epilepsy","volume":"27","author":"Kumar","year":"2007","journal-title":"J Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/pedi.12447","article-title":"Molecular and clinical features of K(ATP) -channel neonatal diabetes mellitus in Japan","volume":"18","author":"Hashimoto","year":"2017","journal-title":"Pediatr. Diabetes."},{"key":"B36","first-page":"87","article-title":"Neonatal diabetes mellitus: description of two Puerto Rican children with KCNJ11 activating gene mutation","volume":"30","author":"Nieves-Rivera","year":"2011","journal-title":"PR Health Sci J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1399-5448.2008.00433.x","article-title":"Diagnosis and treatment of neonatal diabetes: a United States experience","volume":"9","author":"Stoy","year":"2008","journal-title":"Pediatr Diabetes."},{"key":"B38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S2213-8587(18)30106-2","article-title":"Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study","volume":"6","author":"Bowman","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1089\/neu.2018.5986","article-title":"Sulfonylurea receptor 1, transient receptor potential cation channel subfamily m member 4, and kir6.2:role in hemorrhagic progression of contusion","volume":"36","author":"Gerzanich","year":"2019","journal-title":"J Neurotrauma."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/s00125-006-0407-0","article-title":"Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalized epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene","volume":"49","author":"Slingerland","year":"2006","journal-title":"Diabetologia."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.2337\/dc14-2124","article-title":"Remission of severe neonatal diabetes with very early sulfonylurea treatment","volume":"38","author":"Marshall","year":"2015","journal-title":"Diabetes Care."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.2337\/dc11-2439","article-title":"The diagnosis of neonatal diabetes in a mother at 25 years of age","volume":"35","author":"Khurana","year":"2012","journal-title":"Diabetes Care."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s00125-016-3921-8","article-title":"Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes","volume":"59","author":"Babiker","year":"2016","journal-title":"Diabetologia."},{"key":"B44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1515\/JPEM.2011.258","article-title":"AV59M KCNJ11 gene mutation leading to intermediate DEND syndrome in a Chinese child","volume":"24","author":"Sang","year":"2011","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/sj.ejhg.5201629","article-title":"KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features","volume":"14","author":"Gloyn","year":"2006","journal-title":"Eur J Hum Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1399-5448.2009.00548.x","article-title":"Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM","volume":"11","author":"Mohamadi","year":"2010","journal-title":"Pediatr Diabetes."},{"key":"B47","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1515\/JPEM.2009.22.7.661","article-title":"Improved diabetic control during oral sulfonylurea treatment in two children with permanent neonatal diabetes mellitus","volume":"22","author":"Ting","year":"2009","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3346\/jkms.2007.22.4.616","article-title":"Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2","volume":"22","author":"Kim","year":"2007","journal-title":"J Korean Med Sci."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1072078\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T05:36:48Z","timestamp":1677821808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1072078\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":48,"alternative-id":["10.3389\/fneur.2023.1072078"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1072078","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"article-number":"1072078"}}